Inici › Obesitat › Florida › Orlando
Assaigs clínics de Obesitat a Orlando, FL
31 estudis de Obesitat busquen participants en centres de Orlando i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
ReclutantFase 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Reclutant
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
ReclutantFase 1Voluntaris sans benvinguts
- Kailera Clinical Site, Orlando
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
ReclutantFase 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · a 6 mi
- Omega Research Orlando, Altamonte Springs · a 9 mi
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
ReclutantFase 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
ReclutantFase 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · a 5 mi
- K2 Medical Research Maitland LLC, Main Office, Maitland · a 6 mi
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
ReclutantFase 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
ReclutantFase 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
ReclutantFase 3
- Florida Inst For Clin Res LLC, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ReclutantFase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
ReclutantFase 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
ReclutantFase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
ReclutantFase 3
- Clinical Neuroscience Solution, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutantFase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · a 5 mi
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
ReclutantFase 3
- Research Site, Ocoee · a 10 mi
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ReclutantFase 3
- West Orange Endocrinology, Ocoee · a 10 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
ReclutantFase 3
- Conquest Research, Winter Park · a 5 mi
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
ReclutantFase 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
ReclutantFase 3
- AURORA-1 Clinical Site, Winter Park · a 5 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutantFase 3
- AURORA-2 Clinical Site, Winter Park · a 5 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ReclutantFase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · a 5 mi
- i 1 més
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Reclutant
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
ReclutantFase 3Voluntaris sans benvinguts
- ACCOMPLISH-2 Research Site, Ocoee · a 10 mi
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
ReclutantFase 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
ReclutantFase 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
ReclutantFase 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
ReclutantFase 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · a 5 mi
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
ReclutantFase 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
ReclutantFase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · a 5 mi
- K2 Medical Research, Maitland · a 6 mi
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
ReclutantFase 3
- ACCOMPLISH-1 Research Site, Ocoee · a 10 mi
Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
ReclutantVoluntaris sans benvinguts
- AdventHealth Translational Research Institute, Orlando
Assaigs de Obesitat en altres ciutats
- Houston, TX43 estudis
- Chicago, IL41 estudis
- New York City, NY40 estudis
- San Antonio, TX40 estudis
- Washington, DC33 estudis
- Dallas, TX30 estudis
- Boston, MA28 estudis
- Las Vegas, NV27 estudis
- Miami, FL27 estudis
- Baltimore, MD25 estudis
- Jacksonville, FL25 estudis
- St. Louis, MO25 estudis
Altres estudis a Orlando
- Càncer de pulmó de cèl·lules no petites44 estudis
- Càncer metastàtic29 estudis
- Sobrepès27 estudis
- Malaltia d'Alzheimer25 estudis
- Diabetis tipus 224 estudis
- Càncer (tots els tipus)24 estudis
- Càncer de mama23 estudis
- Càncer d'ovari22 estudis
- Colitis ulcerosa22 estudis
- Càncer de pulmó21 estudis
- Càncer colorrectal19 estudis
- Trastorn depressiu major19 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.